As part of FSA’s head-to-head series, we compare the Fidelity Sustainable Healthcare fund and the Polar Capital Biotechnology fund.
Tag: Polar Capital
Is there any point investing in the US actively?
Few active funds come close to the high returns of the index trackers.
Five tech funds outperforming year-to-date
FSA looks at the five top-performing technology funds eligible for distribution in Hong Kong and Singapore.
Is 2022 the year of the toothless tiger?
Investors will need to be brave to take advantage of the opportunities in Chinese equities.
Should investors bet on Covid-19 treatments?
Sentiment toward biotech companies may deteriorate again if efforts to develop treatments for Covid-19 prove to be unsuccessful, according to Polar Capital.
The FSA Spy market buzz – 14 February 2020
Envy Capital’s new CEO; Promotion at UBS; Polar buys value; Blackrock’s foundation for good; Naming financial roles; Event delays; Asset manager outlooks; Bart Simpson and more.
Best and worst active equity funds of the decade
Over the last ten years, new technology funds surged ahead while “old economy” energy and mining funds struggled to stay even.
HEAD-TO-HEAD: Henderson vs Polar Capital
FSA compares the Henderson Horizon Global Technology Fund with the Polar Capital Global Technology Fund.
